| Literature DB >> 33186377 |
Jonathan Golledge1,2,3, Aaron Drovandi1,3, Ramesh Velu2, Frank Quigley4, Joseph Moxon1,3.
Abstract
OBJECTIVE: To assess whether survival and clinical events following elective abdominal aortic aneurysm (AAA) repair were associated with remoteness of residence in North Queensland, Australia.Entities:
Year: 2020 PMID: 33186377 PMCID: PMC7665769 DOI: 10.1371/journal.pone.0241802
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Comparison of risk factors for participants that did or did not die.
| Risk factor | Died (N = 252) | Did not die (N = 274) | P value |
|---|---|---|---|
| Open AAA repair | 89 (35.3%) | 115 (42.0%) | 0.118 |
| Endovascular AAA repair | 163 (64.7%) | 159 (58.0%) | 0.118 |
| Age | 74.7 (69.4–79.3) | 70.6 (65.6–75.0) | |
| Female | 46 (18.3%) | 35 (12.8%) | 0.082 |
| Aboriginal or Torres Strait Islander | 5 (2.0%) | 6 (2.2%) | 0.869 |
| Family history of AAA | 15 (6.0%) | 26 (9.5%) | 0.131 |
| Current smoker | 62 (24.6%) | 78 (28.5%) | 0.316 |
| Diabetes | 45 (17.9%) | 46 (16.8%) | 0.746 |
| Hypertension | 193 (76.6%) | 195 (71.2%) | 0.158 |
| Ischemic heart disease | 143 (56.7%) | 124 (45.3%) | |
| Prior stroke | 24 (9.5%) | 10 (3.6%) | |
| BMI* | 26.9 (23.5–30.4) | 28.0 (25.1–30.8) | |
| Systolic blood pressure† | 134 (120–146) | 132 (120–145) | 0.414 |
| Diastolic blood pressure‡ | 75 (68–81) | 77 (70–83) | 0.250 |
| Anti-platelet drug§ | 141 (56.0%) | 145 (52.9%) | 0.424 |
| Statin§ | 128 (50.8%) | 166 (60.6%) | |
| IRSAD§ | 968 (929–986) | 966 (929–986) | 0.874 |
| Distance from tertiary vascular centre (km)§ | 132 (7–386) | 112 (10–386) | 0.456 |
| Modified Monash classification§ | 0.734 | ||
| 1–2 (large town/city) | 152 (60.3%) | 164 (59.9%) | |
| 3–4 (medium regional town) | 37 (14.7%) | 34 (12.4%) | |
| 5 (small regional town) | 36 (14.3%) | 47 (17.2%) | |
| 6–7 (remote/very remote) | 27 (10.7%) | 27 (9.9%) | |
| Follow-up (years) | 4.8 (2.6–7.3) | 5.7 (2.2–9.6) |
Data are presented as number (percentage), or median (interquartile range). Data only available for 389*, 379†, 378‡, and 524§ participants. IRSAD: Index of Relative Socio-economic Advantage and Disadvantage. Modified Monash Model classification and distance from the tertiary vascular centre were not calculated in two participants visiting from the UK and Papua New Guinea.
Association of measures of remoteness with mortality following abdominal aortic aneurysm repair.
| Remoteness measure | Death | AAA-related events | ||
|---|---|---|---|---|
| Unadjusted | Adjusted | Unadjusted | Adjusted | |
| Modified Monash classification | ||||
| 3–4 (medium regional town) | 0.92 | 0.98 | 0.82 | 0.86 |
| (0.64–1.33) | (0.68–1.42) | (0.34–1.97) | (0.35–2.08) | |
| 5 (small regional town) | 0.91 | 0.91 | 0.52 | 0.55 |
| (0.63–1.31) | (0.63–1.31) | (0.18–1.49) | (0.19–1.56) | |
| 6–7 (remote/very remote) | 1.24 | 1.37 | 2.67 | 2.83 |
| (0.82–1.87) | (0.91–2.07) | (1.33–5.36) | (1.40–5.70) | |
| Distance from tertiary vascular centre | 0.91 | 0.96 | 1.03 | 1.04 |
| (0.81–1.02) | (0.85–1.08) | (0.82–1.31) | (0.82–1.32) | |
This analysis does not include two participants visiting from the UK and Papua New Guinea.
*Reference category is 1–2 (large town/city).
†per 300 km (approximate standard deviation).
‡Adjusted for age, ischemic heart disease, prior stroke and statin prescription. Body mass index not included as missing in 133 participants.
§Adjusted for prior stroke.
Comparison of risk factors for participants that did or did not have an abdominal aortic- related event.
| Risk factor | Abdominal aortic aneurysm-related events | P value | |
|---|---|---|---|
| Open AAA repair | 14 (28.0%) | 190 (39.9%) | 0.100 |
| Endovascular AAA repair | 36 (72.0%) | 286 (60.1%) | 0.100 |
| Age | 74.8 (69.4–78.0) | 72.5 (66.7–77.3) | 0.082 |
| Female | 7 (14.0%) | 74 (15.5%) | 0.773 |
| Aboriginal or Torres Strait Islander | 1 (2.0%) | 10 (2.1%) | 0.962 |
| Family history of AAA | 6 (12.0%) | 35 (7.4%) | 0.244 |
| Current smoker | 12 (24.0%) | 128 (26.9%) | 0.660 |
| Diabetes | 8 (16.0%) | 83 (17.4%) | 0.798 |
| Hypertension | 41 (82.0%) | 347 (72.9%) | 0.164 |
| Ischemic heart disease | 31 (62.0%) | 236 (49.6%) | 0.095 |
| Prior stroke | 8 (16.0%) | 26 (5.5%) | |
| BMI* | 27.2 (24.7–31.3) | 27.4 (24.6–30.6) | 0.850 |
| Systolic blood pressure† | 140 (126–151) | 131 (120–145) | 0.065 |
| Diastolic blood pressure‡ | 79 (70–83) | 75 (69–82) | 0.348 |
| Anti-platelet drug§ | 29 (58.0%) | 257 (54.2%) | 0.610 |
| Statin§ | 33 (66.0%) | 261 (55.1%) | 0.138 |
| IRSAD§ | 966 (928–985) | 967 (929–986) | 0.743 |
| Distance from the tertiary vascular centre | 103 (7–387) | 132 (8–386) § | 0.841 |
| Modified Monash classification | |||
| 1–2 | 29 (58.0%) | 287 (60.5%)§ | |
| 3–4 | 6 (12.0%) | 65 (13.7%)§ | |
| 5 | 4 (8.0%) | 79 (16.7%)§ | |
| 6–7 | 11 (22.0%) | 43 (9.1%)§ | |
| Follow-up | 5.3 (0.5–7.5) | 5.2 (2.7–8.5) | 0.233 |
Data are presented as number (percentage), or median (interquartile range). Data only available for 389*, 379†, 378‡, and 524§ participants. IRSAD: Index of Relative Socio-economic Advantage and Disadvantage. Modified Monash Model classification and distance from the tertiary vascular centre were not calculated for two participants visiting from the UK and Papua New Guinea.